Steady recruitment in VLU Phase IIb
Factor Therapeutics’ update on its Phase IIb venous leg ulcer trial showed that while recruitment has not accelerated as expected in Q217, the...
97 Views
Recruitment in VLU Phase IIb expected to build
Factor Therapeutics updated the market that at the end of Q117, 12 venous leg ulcer (VLU) patients had been randomised to VF-001 or placebo in its...
72 Views
Key venous leg ulcer Phase IIb underway
Factor Therapeutics expects to report top-line results before the end of the year from its randomised Phase IIb trial of VF-001 in venous leg ulcer...
71 Views